Notably, quantitative analysis demonstrated a modest yet statistically significant reduction in both ATXN3 and Galectin-9 in malignant colon adenocarcinoma compared to adjacent normal colon tissues (Fig. 6, B and C). The gene discussed is LGALS9; the disease is colon adenocarcinoma.